Abstract： In this article, recent clinical data of brachytherapy around the world are analyzed and combined with the clinical experience from the author and her research team. The author summarizes the indications, contraindications, target range, dosage, efficacy, and side effects to form a mature brachytherapy regimen. The systematic work may provide a reliable reference for domestic counterparts and be helpful for improving brachytherapy. This article mainly discusses head and neck and thoracic tumors.
Cheng Guanghui. Clinical application of brachytherapy for malignant tumors (1):head and neck and thoracic tumors Cheng Guanghui[J]. Chinese Journal of Radiation Oncology, 2017, 26(5): 489-494.
[1] Tanderup K,Menard C,Polgar C,et al. Advancements in brachytherapy[J].Adv Drug Del Rev,2016.DOI:10.1016/j.addr.2016.09.002. [2] Kwong DLW,Wei WI,Cheng ACK,et al. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma[J].Cancer,2001,91(6):1105-1113. [3] Stoker SD,Diessen JNV,Boer JPD,et al. Current treatment options for local residual nasopharyngeal carcinoma[J].Cur Treat Opt Oncol,2013,14(4):475-491.DOI:10.1007/s11864-013-0261-5. [4] Leung TW,Tung SY,Sze WK,et al. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma[J].Inter J Radiat Oncol Biol Phys,2000,47(2):405-412. [5] Thiagarajan A,Lin K,Tiong CE,et al. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma:an evaluation of long-term outcome[J].Laryngoscope,2006,116(6):938-943.DOI:10.1097/01.MLG.0000215173.14473.D0. [6] 潘建基,吴君心,陈传本,等.鼻咽旁区插植配合体外放射治疗鼻咽癌[J].中华放射肿瘤学杂志,2001,10(1):7-9. Pan JJ,Wu JX,Chen CB,et al. Treatment of nasopharyngeal carcinoma with nasopharyngeal carcinoma and nasopharyngeal carcinoma[J].Chin J Radit Oncol,2001,10(1):7-9. [7] 林少俊,潘建基,吴君心,等.鼻咽癌外照射加腔内近距离超分割推量照射的远期疗效分析[J].癌症,2007,26(2):208-211. Lin SJ,Pan JJ,et al. Long term efficacy analysis of external irradiation plus intracavitary brachytherapy for nasopharyngeal carcinoma[J].Chin J Cancer,2007,26(2):208-211. [8] Rovirosa-Casino A,Planas-Toledano I,Ferre-Jorge J,et al. Brachytherapy in lip cancer[J].Med Oral Patol Oral Y Cirugia Bucal,2006,11(3):E223-9. [9] Ayerra AQ,Mena EP,Fabregas JP,et al. HDR and LDR brachytherapy in the treatment of lip cancer:the experience of the catalan institute of oncology[J].J Contemp Brachyther,2010,1(1):9-13.DOI:10.5114/jcb.2010.13717. [10] Mazeron JJ,Ardiet JM,Haieméder C,et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas[J].Radiother Oncol,2009,91(2):150-156.DOI:0.5114/jcb.2010.13717. [11] Khalilur R,Hayashi K,Shibuya H.Brachytherapy for tongue cancer in the very elderly is an alternative to external beam radiation[J].Br J Radiol,2011,84(1004):747-749.DOI:10.1259/bjr/23130739. [12] Lapeyre M, Peiffert D, Malissard L, et al. An original technique of brachytherapy in the treatment of epidermoid carcinomas of the buccal mucosa[J]. International Journal of Radiation Oncologybiologyphysics, 1995, 33(2):447-454. [13] Pernot M,Hoffstetter S,Peiffert D,et al. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma:reflection of a series of 1344 patients treated at the time of initial presentation[J].Otolaryngol Head Neck Surg,1996,115(6):519-526.DOI:10.1016/S0194-59989670006-2. [14] Lommatzsch P K, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma[J]. Graefe′s Archive for Clinical and Experimental Ophthalmology, 2000, 238(2):129-137. [15] Singh A D, Damato B. Clinical Ophthalmic Oncology[M]. Saunders, 2014:440-440. [16] Müller R P, Busse H, P tter R, et al. Results of high dose 106-ruthenium irradiation of choroidal melanomas[J]. International Journal of Radiation Oncology Biology Physics, 1986, 12(10):1749. [17] R P T, Janssen K, Prott F J, et al. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma:evaluation of 175 patients treated with 150 Gy from 1981-1989[J]. Frontiers of Radiation Therapy& Oncology, 1997, 30:143. [18] Diener-West M, Earle J D, Fine S L, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, Ⅱ:characteristics of patients enrolled and not enrolled. COMS Report No. 17[J]. Archives of Ophthalmology, 2001, 119(7):951. [19] Tselis N,Kolotas C,Birn G,et al. CT-Guided Interstitial HDR Brachytherapy for Recurrent Glioblastoma Multiforme[J].Strahlenther Und Onkol,2007,183(10):563-570.DOI:10.1007/s00066-007-1721-2. [20] Folkert MR,Bilsky MH,Cohen GN,et al. Intraoperative 32P high-dose rate brachytherapy of the dura for recurrent primary and metastatic intracranial and spinal tumors[J].Neurosurgery,2012,71(5):1003-1011.DOI:10.1227/NEU.0b013e31826 d5ac1. [21] Wu N,Zhao H,Han D,et al. Image-guided high-dose-rate interstitial brachytherapy-a valuable salvage treatment approach for loco-regional recurrence of papillary thyroid cancer[J].J Contemp Brachyther,2016,8(2):150-155.DOI:10.5114/jcb.2016.59127. [22] Cuttino LW,Arthur DW,Vicini F,et al. Long-term results from the contura multilumen balloon breast brachytherapy catheter phase 4 registry trial[J].Int J Radiat Oncol Biol Phys,2014,90(5):1025-1029.DOI:10.1016/j.ijrobp.2014.08.341. [23] Poortmans P,Bartelink H,Horiot JC,et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’randomised trial[J].Radiother Oncol,2004,72(1):25-33.DOI:10.1016/j.radonc.2004.03.007. [24] Sioshansi S,Rivard MJ,Hiatt JR,et al. Dose modeling of noninvasive image-guided breast brachytherapy in comparison to electron beam boost and three-dimensional conformal accelerated partial breast irradiation[J].Int J Radiat Oncol Biol Phys,2011,80(2):410-416.DOI:10.1016/j.ijrobp.2010.01.052. [25] Strnad V,Hildebrandt G,P tter R,et al. Accelerated partial breast irradiation:5-year results of the german-austrian multicenter phase Ⅱ trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery[J].Int J Radiat Oncol Biol Phys,2011,80(80):17-24.DOI:10.1016/j.ijrobp.2010.01.020. [26] Poortmans P.Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation[J].New Engl J Med,2001,345(19):1378.DOI:10.1056/NEJMoa010874. [27] Harms W,Krempien R,Hensley FW,et al. Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences[J].Int J Radiat Oncol Biol Phys,2001,49(1):205-210. [28] Wu N,Chen Q,Zhao Z,et al. Interstitial brachytherapy technique for chest wall refractory recurrence of breast cancer[J].J Contemp Brachyther,2015,7(4):290-294.DOI:10.5114/jcb.2015.53868. [29] Mendiondo OA,Dillon M,Beach LJ.Endobronchial brachytherapy in the treatment of recurrent bronchogenic carcinoma[J].Int J Radiat Oncol Biol Phys,1983,9(4):579-582. [30] Nhu-Tram A.Nguyen RKS.Brachytherapy in lung cancer:a review[J].Transl Cancer Res,2015,4(4):381-396.DOI:10.3978/j.issn.2218-676X.2015.08.08. [31] Stewart A,Parashar B,Patel M,et al. American brachytherapy society consensus guidelines for thoracic brachytherapy for lung cancer[J].Brachytherapy,2016,15(1):1.DOI:10.1016/j.brachy.2015.09.006. [32] Chella A,Ambrogi MC,Ribechini A,et al. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement:a prospective randomized study[J].Lung Cancer,2000,27(3):169-175. [33] Marsiglia H,Baldeyrou P,Lartigau E,et al. High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma[J].Int J Radiat Oncol Biol Phys,2000,47(3):665-672. [34] Ozkok S,Karakoyun-Celik O,Goksel T,et al. High dose rate endobronchial brachytherapy in the management of lung cancer:response and toxicity evaluation in 158 patients[J].Lung Cancer,2008,62(62):326-333.DOI:10.1016/j.lungcan.2008.03.018. [35] Fabrini MG,Perrone F,De LM,et al. A single-institutional brachytherapy experience in the management of esophageal cancer[J].Brachytherapy,2010,9(2):185-191.DOI:10.1016/j.brachy.2009.08.006. [36] Sebastian-Lettmaier VS.Intraluminal brachytherapy in oesophageal cancer:defining its role and introducing the technique[J].J Contemp Brachyther,2014,6(2):236.DOI:10.5114/jcb.2014.43780. [37] Ishikawa H,Nonaka T,Sakurai H,et al. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer:long-term follow-up results[J].Int J Radiat Oncol Biol Phys,2010,76(2):452-459.DOI:10.1016/j.ijrobp.2009.02.029. [38] Pasquier D,Mirabel X,Adenis A,et al. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma[J].Int J Radiat Oncol Biol Phys,2006,65(5):1456-1461.DOI:10.1016/j.ijrobp.2006.02.049.
2017, Vol. 26 
